The Centers for Medicare & Medicaid Services plans to convene workgroups and technical expert panels to develop a “streamlined, comprehensive approach to monitoring access across Medicaid delivery systems,” the agency announced yesterday. The workgroups will focus on identifying how the current requirements could be improved; the most effective approach to ensuring beneficiary access to care; how CMS can best ensure states comply with the statutory access requirements; and the best way to align access monitoring across fee-for-service and managed care delivery systems, the agency said. They also will identify data that could be available to conduct access reviews at the federal level and the types of analyses that would be beneficial. CMS yesterday issued a proposed rule that would rescind a 2015 rule requiring states to develop and submit access monitoring review plans to CMS for some Medicaid services. The requirement applies to primary care, physician specialists, behavioral health, pre- and post-natal obstetrics (including labor and delivery), and home health services.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services April 19 approved an amendment to a Massachusetts Medicaid and Children’s Health Insurance Program…
Headline
One in five Medicaid enrollees have been disenrolled since continuous coverage ended last March, a quarter of whom remain uninsured, according to a poll…
Headline
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost…
Headline
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Headline
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…